Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Jagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren’s disease.

Dupuytren's disease affects about 4% of the UK population. It causes fingers to irreversibly curl into the palm, which can be extremely disabling. There is no approved treatment for early disease and patients with established deformities often require surgery to cut or remove the diseased tissue to straighten the fingers.

The winning paper "Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial" explained how Professor Nanchahal's team identified tumour necrosis factor (TNF) as a potential therapeutic target and showed in this trial that injecting a concentrated formulation of anti-TNF directly into the diseased tissue effectively inhibits the cells causing the disease. The team have now completed recruitment to their phase 2b trial in patients with early stage disease to assess if injecting nodules of early stage Dupuytren's disease with a TNF inhibitor prevents disease progression. If successful, patients could receive a simple injection that would preserve hand function and avoid the need for subsequent more invasive treatments.

Professor Nanchahal said, "It is a great honour to receive this award on behalf of my team, and a recognition of our efforts to find a treatment for this debilitating disease."

The International Dupuytren Award, presented annually by the International Dupuytren Society, recognises exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease.

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults